First Market

The first application for the Neuroparticle™ technology is non-invasive treatment for addiction, a $40 billion market.

Follow-On Markets

Subsequent applications will include non-invasive approaches to the many other neurological conditions currently being considered or already reimbursed for treatment with deep brain stimulation, as well as for brain-machine interfaces.

Potential follow-on markets for product